Actually, the drug pricing provision—which might permit Medicare to barter decrease prescription drug costs—seems to be wildly in style amongst a quantity Home Democrats who’re really dealing with stiff reelection odds, because the HuffPost reporter Kevin Robillard wrote in July.
“The primary challenge I hear about in my district is the price of prescribed drugs,” stated Rep. Susan Wild of Pennsylvania, who spearheaded a letter over the summer season urging Democratic management to undertake the drug pricing measure.
Altogether, 15 Democrats signed onto Wild’s letter—all of them a part of the DCCC’s front-line program.
So whereas Democratic members in states like Kansas, Iowa, and Georgia try to do proper by their constituents in a battle for the political lives, those that hail from protected seats in states like New York and California try to doom one of many centerpieces of President Joe Biden’s agenda.
Permitting Medicare to barter drug costs polls higher than maybe another single provision in Democrats’ $3.5 trillion finances invoice. A Kaiser Family Foundation (KFF) poll in Might discovered that “practically 9 in ten (88%) favor permitting the federal authorities to barter for decrease costs on drugs, together with three-fourths (77%) of Republicans, 9 in ten independents (89%) and 96% of Democrats.” The measure can be anticipated to save lots of the federal authorities some $500 billion (give or take) over the course of a decade—financial savings that can then be used to broaden the umbrella of Medicare protection to incorporate dental, imaginative and prescient, and listening to advantages.
So what offers with these conserva-Dems? Cash. Massive Pharma is dispensing large cash to Democrats who voted towards the availability. As HuffPost’s Daniel Marans notes:
- Murphy is the second-highest recipient of Massive Pharma PAC cash in Congress to date this cycle at $54,000 and acquired $117,500 from these PACs within the 2020 cycle.
- Peters, the third-highest recipient of Massive Pharma PAC cash in Congress this cycle at $55,800, acquired $209,300 from these PACs within the 2020 cycle.
- Schrader, the 21st-highest recipient of Massive Pharma PAC cash this cycle at $24,000, acquired $142,000 from these PACs within the 2020 cycle.
Rice’s Massive Pharma PAC haul is not practically as eye-popping at $3,000 to date this cycle and $5,500 final cycle. However Rep. Lou Correa of California, who has additionally made noise about opposing the measure, has taken in $14,500 from Big Pharma PACs this cycle and banked $75,000 last cycle.
The workplace of Home Speaker Nancy Pelosi was fast to reply to the initiatives failure to realize approval within the Power and Commerce Committee.
“Polling persistently exhibits immense bipartisan help for Democrats’ drug worth negotiation laws, together with overwhelming majorities of Republicans and independents who’re fed up with Massive Pharma charging Individuals a lot greater than they cost for a similar medicines abroad,” stated spokesperson Henry Connelly, promising that the initiative would “stay a cornerstone” of the Construct Again Higher Act.
Shortly after that assertion, the Methods and Means panel authorized nearly equivalent drug pricing language.
The key hurdle, nonetheless, is that Pelosi cannot afford to lose greater than three Democrats on the $3.5 trillion finances invoice general. Murphy reportedly expressed optimism about nonetheless supporting the broader package deal, however “no” votes from Peters, Schafer, and Rice would imperil the complete invoice.
These members have additionally introduced themselves as individuals who could invite a main at some point, notably in the event that they vote towards general passage.
“There’s plenty of Democrats in deep blue seats who by no means get critically challenged about how such massive sums of company donations could affect their coverage positions,” stated Waleed Shahid, a spokesperson for Justice Democrats, which works to unseat conserva-Dems in protected seats.